ABBV-1088
- Generic Name
- ABBV-1088
A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088
Phase 1
Recruiting
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 66
- Registration Number
- NCT06579300
- Locations
- 🇺🇸
Acpru /Id# 270552, Grayslake, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath